Publicaciones en las que colabora con ESTELA NATIVIDAD PAZ ARTAL (56)

2024

  1. Enrichment of Immune Dysregulation Disorders in Adult Patients with Human Inborn Errors of Immunity

    Journal of Clinical Immunology, Vol. 44, Núm. 3

2023

  1. Hemodialysis-Associated Immune Dysregulation in SARS-CoV-2-Infected End-Stage Renal Disease Patients

    International Journal of Molecular Sciences, Vol. 24, Núm. 2

  2. Inborn Error of STAT2-Dependent IFN-I Immunity in a Patient Presented with Hemophagocytic Lymphohistiocytosis and Multisystem Inflammatory Syndrome in Children

    Journal of Clinical Immunology, Vol. 43, Núm. 6, pp. 1278-1288

  3. Novel Germline TET2 Mutations in Two Unrelated Patients with Autoimmune Lymphoproliferative Syndrome-Like Phenotype and Hematologic Malignancy

    Journal of Clinical Immunology, Vol. 43, Núm. 1, pp. 165-180

  4. Rare predicted loss-of-function variants of type I IFN immunity genes are associated with life-threatening COVID-19

    Genome Medicine, Vol. 15, Núm. 1

  5. Vaccine breakthrough hypoxemic COVID-19 pneumonia in patients with auto-Abs neutralizing type I IFNs

    Science immunology, Vol. 8, Núm. 90, pp. eabp8966

2022

  1. An Early Th1 Response Is a Key Factor for a Favorable COVID-19 Evolution

    Biomedicines, Vol. 10, Núm. 2

  2. Effective Natural Killer Cell Degranulation Is an Essential Key in COVID-19 Evolution

    International Journal of Molecular Sciences, Vol. 23, Núm. 12

  3. Immunogenicity of Anti-SARS-CoV-2 Vaccines in Common Variable Immunodeficiency

    Journal of Clinical Immunology, Vol. 42, Núm. 2, pp. 240-252

2021

  1. Beta-2-Glycoprotein-I Deficiency Could Precipitate an Antiphospholipid Syndrome-like Prothrombotic Situation in Patients With Coronavirus Disease 2019

    ACR Open Rheumatology, Vol. 3, Núm. 4, pp. 267-276

  2. Immunologic evaluation and genetic defects of apoptosis in patients with autoimmune lymphoproliferative syndrome (ALPS)

    Critical Reviews in Clinical Laboratory Sciences, Vol. 58, Núm. 4, pp. 253-274

  3. Initial presenting manifestations in 16,486 patients with inborn errors of immunity include infections and noninfectious manifestations

    Journal of Allergy and Clinical Immunology, Vol. 148, Núm. 5, pp. 1332-1341.e5

  4. Longitudinal dynamics of SARS-CoV-2-specific cellular and humoral immunity after natural infection or BNT162b2 vaccination

    PLoS Pathogens, Vol. 17, Núm. 12

  5. Next Generation Sequencing for Detecting Somatic FAS Mutations in Patients With Autoimmune Lymphoproliferative Syndrome

    Frontiers in Immunology, Vol. 12

  6. Primary Immune Regulatory Disorders With an Autoimmune Lymphoproliferative Syndrome-Like Phenotype: Immunologic Evaluation, Early Diagnosis and Management

    Frontiers in Immunology, Vol. 12

  7. T-Helper Cell Subset Response Is a Determining Factor in COVID-19 Progression

    Frontiers in Cellular and Infection Microbiology, Vol. 11

2020

  1. Autoantibodies against type I IFNs in patients with life-threatening COVID-19

    Science, Vol. 370, Núm. 6515

  2. Inborn errors of type I IFN immunity in patients with life-threatening COVID-19

    Science, Vol. 370, Núm. 6515

  3. Perforin gene variant A91V in young patients with severe COVID-19

    Haematologica

2019

  1. Acquired and innate immunity impairment and severe disseminated Mycobacterium genavense infection in a patient with a NF-κB1 deficiency

    Frontiers in Immunology, Vol. 10, Núm. JAN